Your browser doesn't support javascript.
loading
Successful treatment with bortezomib for refractory fever associated with myelodysplastic syndrome with underlying lymphoplasmacytic lymphoma.
Motomura, Yotaro; Umezawa, Yoshihiro; Arimatsu, Tomoyuki; Okada, Keigo; Miura, Osamu; Kumagai, Takashi.
Afiliación
  • Motomura Y; Department of Hematology Ome Municipal General Hospital Tokyo Japan.
  • Umezawa Y; Department of Hematology Tokyo Medical and Dental University Tokyo Japan.
  • Arimatsu T; Department of Hematology Ome Municipal General Hospital Tokyo Japan.
  • Okada K; Department of Hematology Ome Municipal General Hospital Tokyo Japan.
  • Miura O; Department of Hematology Tokyo Medical and Dental University Tokyo Japan.
  • Kumagai T; Department of Hematology Ome Municipal General Hospital Tokyo Japan.
Clin Case Rep ; 10(2): e05372, 2022 Feb.
Article en En | MEDLINE | ID: mdl-35154721
ABSTRACT
We report a case of fever of unknown origin in a patient with MDS associated with IgM-MGUS. The patient was positive for MYD88 mutation, and chemotherapy for LPL/WM improved the fever. Analysis of MYD88 and the effect of chemotherapy on LPL/WM finally revealed the latent LPL/WM in this case.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Clin Case Rep Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Risk_factors_studies Idioma: En Revista: Clin Case Rep Año: 2022 Tipo del documento: Article